The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma

BACKGROUND: Bortezomib has significant activity in treating multiple myeloma (MM). The risk of herpes zoster (HZ) has been reported to increase significantly with bortezomib treatment, but the predisposing factors for HZ are not clear. This study is a retrospective analysis of the relevant risk fact...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yi, Yang-Seon, Chung, Joo-Seop, Song, Moo-Kon, Shin, Ho-Jin, Seol, Young-Mi, Choi, Young-Jin, Cho, Goon-Jae, Lee, Gyeong-Won, Moon, Joon-Ho, Hwang, In-Hye, Ahn, Kang-Hee, Lee, Hee-Sun, Shin, Kyung-Hwa, Hwang, Jong-Min
Format: Artigo
Jezik:Inglês
Izdano: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2983043/
https://ncbi.nlm.nih.gov/pubmed/21120208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/kjh.2010.45.3.188
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki